Subscribe

Butterfly Network Raises $76.5M in Public Offering

By

Ethan Carter

Disclaimer: Images on MEDWIRE.AI are AI-generated for illustrative purposes and are not affiliated with, endorsed by, or representative of any specific company, product, or technology.

Funds to Support Product Development & Growth

Butterfly Network (NYSE: BFLY) expects $76.5 million from its public offering of 24M shares at $3.15 each.

Key Highlights:

  • Stock Performance: Up 6% this week, trading above $4.
  • Growth Acceleration: 35% Q4 revenue increase, surpassing expectations.
  • CEO Joseph DeVivo: “Success comes from relentless execution & exceptional products.”

Follow MEDWIRE.AI for more updates on medical technology investments.

RECOMMENDED READS

Philips, Mass General Brigham Partner on AI-Powered Patient Care
Philips, Mass General Brigham Partner on AI-Powered Patient Care
Synchron Partners with Nvidia to Advance AI-Driven BCI Technology
Synchron Partners with Nvidia to Advance AI-Driven BCI Technology
Qure.ai Appoints MedTech Veteran Jim Mercadante as Chief Commercial Officer
Qure.ai Appoints MedTech Veteran Jim Mercadante as Chief Commercial...
FDA Releases Draft Guidance on AI-Enabled Medical Devices
FDA Releases Draft Guidance on AI-Enabled Medical Devices
AI-Driven Cardiac Devices Transform Heart Disease Care
AI-Driven Cardiac Devices Transform Heart Disease Care
Taiwan Showcases AI Surgical Innovations at MEDICA 2024
Taiwan Showcases AI Surgical Innovations at MEDICA 2024
Linkedin

Get the MEDWIRE.AI Newsletter

Stay ahead in MedTech with industry updates, breakthroughs, and expert
insights—delivered straight to your inbox.

© 2025 MEDWIRE.AI. All rights reserved. MEDWIRE.AI is a trusted source for MedTech news and insights. Our website content and services are for informational purposes only. MEDWIRE.AI does not provide medical advice, diagnosis, or treatment.

Subscribe